Replimune Group Stock

Replimune Group Gross Margin

Gross Margin of Replimune Group (REPL) as of Aug 4, 2026.

Gross Margin

0.00

Last updated:

Gross Margin of Replimune Group is 2026 0.00 . Gross Margin of Replimune Group was 2025 0.00 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Replimune Group Stock analysis

What does Replimune Group do? Replimune Group Inc is an American biotechnology company based in Woburn, Massachusetts. The company focuses on the development of therapeutics for cancer treatments through the application of oncolytic viruses. Replimune Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Replimune Group stock

On Eulerpool you can find the complete historical development of Gross Margin Replimune Group since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Replimune Group with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

Margins — Replimune Group

All Key Metrics — Replimune Group